View in EDS

Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer.

Saved in:
Bibliographic Details
Title: Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer.
Authors: Matossian MD; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors., Hoang VT; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors., Burks HE; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors., La J; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors., Elliott S; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA., Brock C; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA., Rusch DB; Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN 47405, USA., Buechlein A; Medical Sciences Program, Indiana University School of Medicine-Bloomington, Bloomington, IN 47405, USA., Nephew KP; Medical Sciences Program, Indiana University School of Medicine-Bloomington, Bloomington, IN 47405, USA., Bhatt A; Department of Pharmacology, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA., Cavanaugh JE; Department of Pharmacology, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA., Flaherty PT; Department of Medicinal Chemistry, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA., Collins-Burow BM; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; Tulane Cancer Center, New Orleans, LA 70112, USA., Burow ME; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.
Source: Oncoscience [Oncoscience] 2021 May 18; Vol. 8, pp. 64-71. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals LLC Country of Publication: United States NLM ID: 101636666 Publication Model: eCollection Cited Medium: Print ISSN: 2331-4737 (Print) Linking ISSN: 23314737 NLM ISO Abbreviation: Oncoscience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34026925
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Matossian+MD%22">Matossian MD</searchLink>; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors.<br /><searchLink fieldCode="AU" term="%22Hoang+VT%22">Hoang VT</searchLink>; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors.<br /><searchLink fieldCode="AU" term="%22Burks+HE%22">Burks HE</searchLink>; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors.<br /><searchLink fieldCode="AU" term="%22La+J%22">La J</searchLink>; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; These authors contributed equally to this work and are shared first authors.<br /><searchLink fieldCode="AU" term="%22Elliott+S%22">Elliott S</searchLink>; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.<br /><searchLink fieldCode="AU" term="%22Brock+C%22">Brock C</searchLink>; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.<br /><searchLink fieldCode="AU" term="%22Rusch+DB%22">Rusch DB</searchLink>; Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN 47405, USA.<br /><searchLink fieldCode="AU" term="%22Buechlein+A%22">Buechlein A</searchLink>; Medical Sciences Program, Indiana University School of Medicine-Bloomington, Bloomington, IN 47405, USA.<br /><searchLink fieldCode="AU" term="%22Nephew+KP%22">Nephew KP</searchLink>; Medical Sciences Program, Indiana University School of Medicine-Bloomington, Bloomington, IN 47405, USA.<br /><searchLink fieldCode="AU" term="%22Bhatt+A%22">Bhatt A</searchLink>; Department of Pharmacology, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA.<br /><searchLink fieldCode="AU" term="%22Cavanaugh+JE%22">Cavanaugh JE</searchLink>; Department of Pharmacology, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA.<br /><searchLink fieldCode="AU" term="%22Flaherty+PT%22">Flaherty PT</searchLink>; Department of Medicinal Chemistry, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA.<br /><searchLink fieldCode="AU" term="%22Collins-Burow+BM%22">Collins-Burow BM</searchLink>; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.; Tulane Cancer Center, New Orleans, LA 70112, USA.<br /><searchLink fieldCode="AU" term="%22Burow+ME%22">Burow ME</searchLink>; Department of Medicine, Division of Hematology and Oncology, Tulane University, New Orleans, LA 70118, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101636666%22">Oncoscience</searchLink> [Oncoscience] 2021 May 18; Vol. 8, pp. 64-71. <i>Date of Electronic Publication: </i>2021 May 18 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals+LLC%22">Impact Journals LLC </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101636666 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2331-4737 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223314737%22">23314737 </searchLink><i>NLM ISO Abbreviation: </i>Oncoscience <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34026925
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncoscience.535
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 64
    Titles:
      – TitleFull: Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matossian MD
      – PersonEntity:
          Name:
            NameFull: Hoang VT
      – PersonEntity:
          Name:
            NameFull: Burks HE
      – PersonEntity:
          Name:
            NameFull: La J
      – PersonEntity:
          Name:
            NameFull: Elliott S
      – PersonEntity:
          Name:
            NameFull: Brock C
      – PersonEntity:
          Name:
            NameFull: Rusch DB
      – PersonEntity:
          Name:
            NameFull: Buechlein A
      – PersonEntity:
          Name:
            NameFull: Nephew KP
      – PersonEntity:
          Name:
            NameFull: Bhatt A
      – PersonEntity:
          Name:
            NameFull: Cavanaugh JE
      – PersonEntity:
          Name:
            NameFull: Flaherty PT
      – PersonEntity:
          Name:
            NameFull: Collins-Burow BM
      – PersonEntity:
          Name:
            NameFull: Burow ME
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 05
              Text: 2021 May 18
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2331-4737
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: Oncoscience
              Type: main
ResultId 1